We are closely monitoring the global pharmaceutical manufacturing environment and working with our suppliers to ensure we can continue filling prescriptions for pharmacy patients and plan members. We are actively managing our supply to ensure our ability to continue to fill prescriptions in our retail, mail and specialty pharmacies.
We’re also balancing the growing interest in off-label use of certain prescription medications to treat COVID-19 pneumonia with the ongoing needs of patients and members who are prescribed these drugs to help manage chronic conditions such as lupus, HIV, rheumatoid arthritis and asthma. Our goal is to limit stockpiling of medication that could result in future shortages and gaps in care.
Our retail pharmacies are following dispensing guidelines regarding the use of these medications for COVID-19 that have been established in certain states. In states with no guidelines, our pharmacies are limiting the dispensing for COVID-19 treatment to a 10-day supply with no refills.
With consent of plan sponsors, CVS Caremark is setting appropriate coverage limits on the quantity of these medications for potential use in treating COVID-19. Plan members who already take these medications for approved uses will be able to bypass the new quantity limits.